Cancer Research The Future of Cancer Research: Science and Patient Impact  AACR Conference on Molecular Diagnostics - 2008
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 57, 259-266, January 15, 1997]
© 1997 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Staretz, M. E.
Right arrow Articles by Hecht, S. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Staretz, M. E.
Right arrow Articles by Hecht, S. S.

Evidence for an Important Role of DNA Pyridyloxobutylation in Rat Lung Carcinogenesis by 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone: Effects of Dose and Phenethyl Isothiocyanate1

Marianne E. Staretz, Peter G. Foiles2, Lisa M. Miglietta2 and Stephen S. Hecht3

American Health Foundation, Valhalla, New York 10595

The tobacco-specific nitrosamine, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK), selectively induces lung tumors in F344 rats. NNK is metabolically activated to intermediates that methylate and pyridyloxobutylate DNA. To explore the importance of pyridyloxobutyl DNA adducts in NNK-induced rat lung tumorigenesis, the first study in this report examined levels of these adducts in whole lung and pulmonary cells of F344 rats treated with different doses of NNK (0.3, 1.0, 10.0, and 50 mg/kg; 3 x weekly for 2 weeks). Pyridyloxobutyl DNA adducts were highest in Clara cells compared to alveolar Type II cells, alveolar macrophages, and small cells, suggesting that enzymes involved in the formation of the pyridyloxobutylating species are concentrated in Clara cells. When we compared lung tumor incidence at the different doses of NNK (S. A. Belinsky et al., Cancer Res., 50: 3772–3780, 1990) versus pyridyloxobutyl DNA adducts in Type II cells, we observed a significant correlation. Because NNK-induced lung tumors arise from the Type II cells, this suggests an important role for pyridyloxobutyl DNA adducts. In the second study presented in this report, we examined the effect of dietary phenethyl isothiocyanate (PEITC), an inhibitor of lung tumor induction in F344 rats by NNK, on O6-methyldeoxyguanosine (O6-mG) and pyridyloxobutyl DNA adducts in whole lung and lung cells of F344 rats treated with NNK. F344 rats were fed control or PEITC-containing diets (3 µmol/g diet) before and throughout NNK treatment (1.76 mg/kg, three times weekly for 4, 8, 12, 16, or 20 weeks). PEITC inhibited formation of pyridyloxobutyl DNA adducts in whole lung and all lung cells except macrophages. There was also inhibition of O6-mG, but it varied with cell type and length of NNK treatment. Overall, PEITC treatment decreased pyridyloxobutyl DNA adducts by 57% in Clara cells, 51% in Type II cells, 40% in small cells, and 44% in whole lung. PEITC treatment decreased O6-mG levels by 52% in Clara cells, 19% in Type II cells and small cells, and 36% in whole lung. These results support the hypothesis that PEITC inhibition of NNK-induced lung tumors is a result of decreased metabolic activation and DNA binding of NNK. The 50% reduction of pyridyloxobutyl DNA adducts in Type II cells agreed well with the 50% reduction of NNK-induced lung tumors by PEITC. Because NNK-induced tumors arise from Type II cells, these results suggest an important role for pyridyloxobutyl DNA adducts in NNK-induced rat lung tumorigenesis.

1 This study was supported by Grant CA-46535 from the National Cancer Institute.

2 Present address: Alteon, Inc., Ramsey, NJ 07446.

3 To whom requests for reprints should be addressed, at University of Minnesota Cancer Center, Box 806-UMHC, 420 Delaware St. SE, Minneapolis, MN 55455.

Received 8/12/96. Accepted 11/14/96.




This article has been cited by other articles:


Home page
Cancer Res.Home page
Y. Weng, C. Fang, R. J. Turesky, M. Behr, L. S. Kaminsky, and X. Ding
Determination of the Role of Target Tissue Metabolism in Lung Carcinogenesis Using Conditional Cytochrome P450 Reductase-Null Mice
Cancer Res., August 15, 2007; 67(16): 7825 - 7832.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J.-Y. Choi, G. Chowdhury, H. Zang, K. C. Angel, C. C. Vu, L. A. Peterson, and F. P. Guengerich
Translesion Synthesis across O6-Alkylguanine DNA Adducts by Recombinant Human DNA Polymerases
J. Biol. Chem., December 15, 2006; 281(50): 38244 - 38256.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
R. S. Mijal, S. Kanugula, C. C. Vu, Q. Fang, A. E. Pegg, and L. A. Peterson
DNA Sequence Context Affects Repair of the Tobacco-Specific Adduct O6-[4-Oxo-4-(3-pyridyl)butyl]guanine by Human O6-Alkylguanine-DNA Alkyltransferases.
Cancer Res., May 1, 2006; 66(9): 4968 - 4974.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
G. Boysen, P. M.J. Kenney, P. Upadhyaya, M. Wang, and S. S. Hecht
Effects of benzyl isothiocyanate and 2-phenethyl isothiocyanate on benzo[a]pyrene and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone metabolism in F-344 rats
Carcinogenesis, March 1, 2003; 24(3): 517 - 525.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
K. R.K. Sticha, P. M.J. Kenney, G. Boysen, H. Liang, X. Su, M. Wang, P. Upadhyaya, and S. S. Hecht
Effects of benzyl isothiocyanate and phenethyl isothiocyanate on DNA adduct formation by a mixture of benzo[a]pyrene and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in A/J mouse lung
Carcinogenesis, September 1, 2002; 23(9): 1433 - 1439.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
L. A. Peterson, N. M. Thomson, D. L. Crankshaw, E. E. Donaldson, and P. J. Kenney
Interactions between Methylating and Pyridyloxobutylating Agents in A/J Mouse Lungs: Implications for 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced Lung Tumorigenesis
Cancer Res., August 1, 2001; 61(15): 5757 - 5763.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
S. S. Hecht, S. G. Carmella, and S. E. Murphy
Effects of Watercress Consumption on Urinary Metabolites of Nicotine in Smokers
Cancer Epidemiol. Biomarkers Prev., October 1, 1999; 8(10): 907 - 913.
[Abstract] [Full Text]


Home page
CarcinogenesisHome page
G. B.J. Smith, A. Castonguay, P. J. Donnelly, K. R. Reid, D. Petsikas, and T. E. Massey
Biotransformation of the tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in freshly isolated human lung cells
Carcinogenesis, September 1, 1999; 20(9): 1809 - 1818.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
H. M. Schuller, P. K. Tithof, M. Williams, and H. Plummer III
The Tobacco-specific Carcinogen 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone Is a {beta}-Adrenergic Agonist and Stimulates DNA Synthesis in Lung Adenocarcinoma via {beta}-Adrenergic Receptor-mediated Release of Arachidonic Acid
Cancer Res., September 1, 1999; 59(18): 4510 - 4515.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
L. Liu, X. Qin, and S. L. Gerson
Reduced lung tumorigenesis in human methylguanine DNA—methyltransferase transgenic mice achieved by expression of transgene within the target cell
Carcinogenesis, February 1, 1999; 20(2): 279 - 284.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
C. C. Conaway, D. Jiao, T. Kohri, L. Liebes, and F.-L. Chung
Disposition and Pharmacokinetics of Phenethyl Isothiocyanate and 6-Phenylhexyl Isothiocyanate in F344 Rats
Drug Metab. Dispos., January 1, 1999; 27(1): 13 - 20.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1997 by the American Association for Cancer Research.